These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9126305)

  • 41. [PyNPase expression and cancer progression in the colorectum].
    Monden T; Haba A; Amano M; Kanoh T; Tsujie M; Ikeda K; Izawa H; Ohnishi T; Sekimoro M; Tomita N; Okamura J; Monden M
    Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):446-51. PubMed ID: 9742526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.
    Fujimoto K; Matsumura Y; Tani Y; Ozono S; Hirao Y; Okajima E
    Int J Urol; 2007 Aug; 14(8):754-9. PubMed ID: 17681069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):951-8. PubMed ID: 10396323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High level concentration of pyrimidine nucleoside phosphorylase in esophageal squamous cell carcinoma but no correlation with clinicopathological parameters.
    Noguchi T; Moriyama H; Wada S; Takeno S; Kimura Y; Uchida Y; Gabbert HE
    Dis Esophagus; 2003; 16(4):307-11. PubMed ID: 14641294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Preoperative chemotherapy for advanced colorectal carcinomas--comparison of histological effect between 5'-DFUR + leucovorin tablet and 5'-DFUR alone].
    Maruyama M; Toukairin Y; Baba H; Yoshida T; Kure N; Nagahama T; Ebuchi M
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):499-504. PubMed ID: 11329784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of orally administered 5-fluorouracil and its derivative 5'-deoxy-5-fluorouridine on 7,12-dimethylbenz[a]anthracene-induced breast carcinomas in rats.
    Sawada Y; Ohno T; Shimoyama T; Uematsu K; Odagiri H
    J Int Med Res; 1991; 19(3):249-70. PubMed ID: 1834492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of the pharmacokinetics of 5'-deoxy-5-fluorouridine and 5-fluorouracil in rats by oral co-administration of acyclothymidine.
    Hamada A; Fukushima S; Saneyoshi M; Shimizu S; Kawaguchi T; Nakano M
    Biol Pharm Bull; 1996 May; 19(5):729-32. PubMed ID: 8741584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinicopathological significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced colorectal cancer].
    Otsuka S; Tanabe S; Tsunemitsu Y; Ariki N; Miyoshi K; Inagaki M; Takahashi M; Oosaki T; Fuchimoto S; Yumura M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1679-81. PubMed ID: 16315907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of pyrimidine nucleoside phosphorylase activity on metastasis of breast cancer.
    Hideshima T; Yamashita J; Maekawa T; Sakai T; Baba M; Ogawa M; Shirakusa T
    Oncol Rep; 1997; 4(4):795-8. PubMed ID: 21590142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nakano Y; Ohota J; Fujita M; Taguchi T
    Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acyclothymidine alleviates intestinal toxicity of 5'-deoxy-5-fluorouridine without loss of antitumor activity in mice.
    Hamada A; Fukushima S; Saneyoshi M; Shimizu S; Kawaguchi T; Nakano M
    Biol Pharm Bull; 1996 Oct; 19(10):1362-6. PubMed ID: 8913513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PyNPase expression in human colon cancer.
    Haba A; Monden T; Sekimoto M; Ikeda K; Izawa H; Kanou T; Amano M; Kan'yama H; Monden M
    Cancer Lett; 1998 Jan; 122(1-2):85-92. PubMed ID: 9464495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A new anticancer drug, 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2977-82. PubMed ID: 2959207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A comparative study of 5'-DFUR and tegafur in recurrent breast cancer].
    Taguchi T; Terasawa T; Abe O; Yoshida Y; Tominaga T; Ogawa N
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2052-60. PubMed ID: 2932060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
    Suzuki M; Aida I; Ohwada M; Sato I; Tamura T; Kasuga Y
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):253-8. PubMed ID: 7857101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical trial of 5'-DFUR in patients with recurrent breast cancer].
    Morimoto T; Komaki K; Yamakawa T; Tanaka T; Konishi Y; Uomine Y; Miki H; Ooshimo K; Monden Y
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2983-9. PubMed ID: 2972258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.
    Yamagata M; Mori M; Mimori K; Mafune KI; Tanaka Y; Ueo H; Akiyoshi T
    Br J Cancer; 1999 Feb; 79(3-4):565-9. PubMed ID: 10027331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case of advanced breast cancer responding to low-dose 5'-DFUR].
    Koh J; Murayama Y; Sano M; Katai H; Maeda K; Sakai S; Yamamoto O; Hashimoto M; Hosoda Y
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1063-6. PubMed ID: 1385689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group.
    Shimane Breast Cancer Study Group
    Anticancer Res; 2006; 26(1B):591-7. PubMed ID: 16739326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of intestinal pyrimidine nucleoside phosphorylases.
    Wientjes MG; Au JL
    Pharm Res; 1987 Oct; 4(5):425-8. PubMed ID: 2977647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.